Serum BMP-2 and BMP-4 levels and their relationship with disease activity in patients with rheumatoid arthritis and ankylosing spondylitis

Ali Erhan Özdemirel, Serdar Can Güven, Zühre Sarı Sürmeli, Ayla Özyuvalı, Memet Kurt, Diana Rüstemova, Ayşe Peyman Yalçın Sayan, Hüseyin Tutkan, Şebnem Ataman

DOI: 10.46497/ArchRheumatol.2022.9819

Issue: Volume 37 - Issue 3 - September 2022
1291 997

Validity and reliability of the Turkish version of Psoriasis Epidemiology Screening Tool for the detection of psoriatic arthritis in patients with psoriasis

Serdar Kaymaz, Uğur Karasu, Nida Kaçar, Hakan Alkan

DOI: 10.46497/ArchRheumatol.2022.8221

Issue: Volume 37 - Issue 4 - December 2022
939 939

The association of urinary plasmin level with renal involvement and disease flare among systemic lupus erythematosus patients

Rasha Fawzy, Mounir Serag, Amal Soliman, Sania Elwia, Samia Mojahed

DOI: 10.46497/ArchRheumatol.2022.9307

Issue: Volume 37 - Issue 4 - December 2022
923 841

Insulin resistance and adverse lipid profile in untreated very early rheumatoid arthritis patients: A single-center, cross-sectional study in China

Lu Ye, Xin Zhang, Huaxiang Wu, Yahui Chen, Haibo Zhou, Qiaohong Wang, Weihong Xu

DOI: 10.46497/ArchRheumatol.2022.9117

Issue: Volume 37 - Issue 4 - December 2022
953 1048

Serum cystatin C and βeta-2 microglobulin as potential biomarkers in children with lupus nephritis

Eman Baraka, Nashwa Hashaad, Walid Abdelhalim, Gehan Elolemy

DOI: 10.46497/ArchRheumatol.2023.8520

Issue: Volume 38 - Issue 1 - March 2023
798 844

Muscle architecture in patients with primary Sjögren syndrome

Duygu Tecer, Dilek Eker Büyüksireci, Zafer Günendi, Jale Meray, Feride Göğüs

DOI: 10.46497/ArchRheumatol.2023.9414

Issue: Volume 38 - Issue 1 - March 2023
723 817

Proprotein convertase subtilisin/kexin 9 (PCSK9) in patients with diffuse systemic sclerosis: A marker of disease activity and severe disease manifestations with potential therapeutic implementations

Joy Artin, Yumn A. Elsabagh, Laila Rashed, Mohamed A. Hussein

DOI: 10.46497/ArchRheumatol.2023.9638

Issue: Volume 38 - Issue 2 - June 2023
553 623

Examining the functions of the vascular endothelial growth factor/hypoxia-inducible factor signaling pathway in psoriatic arthritis

Yavuz Kiliç, Derya Guzel Erdogan, Merve Baykul, Kemal Nas

DOI: 10.46497/ArchRheumatol.2023.9898

Issue: Volume 38 - Issue 4 - December 2023
478 542

Secukinumab after first-line tumor necrosis factor-alpha inhibitor therapy in psoriatic arthritis: A real-world retrospective cohort study

Tumay Ak, Leyla Mustafayeva, Ali Yagiz Ayla, Yeliz Celik, Gunay Can, Serdal Ugurlu

DOI: 10.46497/ArchRheumatol.2024.10050

Issue: Volume 39 - Issue 1 - March 2024
267 322

Correlation between clinical disease activity and sacroiliac magnetic resonance imaging detection in axial spondyloarthropathy

Ozenc Inan, Ebru Aytekin, Yasemin Pekin Dogan, Ilhan Nahit Mutlu, Kübra Aydemir, Nuran Oz, Nil Sayiner Caglar

DOI: 10.46497/ArchRheumatol.2024.10401

Issue: Volume 39 - Issue 1 - March 2024
244 276

The relationship between clinical parameters and ultrasonographic enthesitis assessment in patients with spondyloarthritis

Gunay Er, Deniz Palamar, Kenan Akgün, İbrahim Asoğlu, Hidayet Sarı

DOI: 10.46497/ArchRheumatol.2024.10224

Issue: Online First
0 4396